Lesion Clinical Trials in Dallas, Texas
7 recruitingDallas, Texas
Showing 1–7 of 7 trials
Recruiting
Not Applicable
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Coronary Arterial Disease (CAD)de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation1,616 enrolled50 locationsNCT06959524
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
Focal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion
Sanofi84 enrolled69 locationsNCT06500702
Recruiting
Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry
Soft Tissue Lesion
Galvanize Therapeutics, Inc.1,000 enrolled10 locationsNCT05851430
Recruiting
Not Applicable
TECTONIC CAD IVL IDE Study
Coronary Artery DiseaseCoronary Artery CalcificationStenotic Coronary Lesion
Abbott Medical Devices335 enrolled41 locationsNCT06885177
Recruiting
Not Applicable
Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems
Intra-axial TumorsExtra-axial TumorsInfection/Inflammatory Lesions
Hyperfine85 enrolled3 locationsNCT07296263
Recruiting
Phase 3
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
Uveal MelanomaChoroidal MelanomaIndeterminate Lesions+1 more
Aura Biosciences100 enrolled71 locationsNCT06007690
Recruiting
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
Choroidal MelanomaIndeterminate Lesions of Eye
Aura Biosciences500 enrolled16 locationsNCT03941379